A violent storm may have sent two baby pterosaurs spiraling to their deaths in a lagoon about 150 million years ago, based on a new analysis of the tiny, astonishingly ...

The Nebraska Leadership Education/Action Development (LEAD) program has announced the selection of 27 individuals as fellows ...

The LINKER-SMM1 trial evaluates linvoseltamab's safety and efficacy in high-risk smoldering multiple myeloma, aiming to delay disease progression.

Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients with a complete response in remission after four years1Subcutaneous Lunsumio has potential to ...

Polyclonal antithymocyte globulin (ATG), an old agent used to suppress the immune system and destroy T cells, reduced the ...

The FDA has approved the biologics license application (BLA) for the subcutaneous (SC) administration of pembrolizumab ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple ...

As Indian Millennials go through midlife, there are no Ferraris, no meltdowns, no torrid affairs. They’re not breaking free, they’re taking breaks. There’s less panicking, more pivoting. And at every ...

SHANGHAI, NANJING, China and PLEASANTON, Calif., Sept. 18, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a ...

Following its Type A meeting with the FDA, Replimune reported that a forward pathway “has not been determined” to obtain ...

Skate Culture to host Rock & Roll Sock Hop Skate in Alton ...